The DOI matches its Crossref record; 229 of the 229 references it cites were found in a registry or an index.
Histone Modifications and Cancer
Open accessAbstract
Histone posttranslational modifications represent a versatile set of epigenetic marks involved not only in dynamic cellular processes, such as transcription and DNA repair, but also in the stable maintenance of repressive chromatin. In this article, we review many of the key and newly identified histone modifications known to be deregulated in cancer and how this impacts function. The latter part of the article addresses the challenges and current status of the epigenetic drug development process as it applies to cancer therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Lysyl Oxidase-like 2 Deaminates Lysine 4 in Histone H3
Herranz, N., Dave, N., Millanes‐Romero, A., Morey, L., Diaz, V. M., Lorenz, V., Gallego, R. G., Jerónimo, C., Croce, L. D., de Herreros, A. G., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.03.002 · Cited by 80
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Chromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
Regulation of chromatin by histone modifications
Bannister, A. J., & Kouzarides, T. (2011) · Cell Research · doi:10.1038/cr.2011.22 · Cited by 6,012
Chen, X., Xiu, M., Xing, J., Yu, S., Min, D., & Guo, F. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479439 · Cited by 5,742
Jones, P. A., & Baylin, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.01.029 · Cited by 4,515
Selective inhibition of BET bromodomains
Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., et al. (2010) · Nature · doi:10.1038/nature09504 · Cited by 4,262
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Delmore, J. E., Issa, G. C., Lemieux, M. E., Rahl, P. B., Shi, J., Jacobs, H. M., Kastritis, E., Gilpatrick, T., Paranal, R. M., Qi, J., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.017 · Cited by 2,813
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sharma, S. V., Lee, D. Y., Li, B., Quinlan, M. P., Takahashi, F., Maheswaran, S., McDermott, U., Azizian, N., Zou, L., Fischbach, M. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.02.027 · Cited by 2,770
HDAC6 is a microtubule-associated deacetylase
Hubbert, C., Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., Yoshida, M., Wang, X.-F., & Yao, T.-P. (2002) · Nature · doi:10.1038/417455a · Cited by 2,403 · cited 1×
“Among the many known examples are HDAC6, SIRT1, SIRT2, SET7/9, SETD8, SMYD2, PRMT5, and EHMT2/G9a) (Hubbert et al. 2002; Huang et al. 2006; Shi et al. 2007; Pradhan et al. 2009; Karkhanis et al. 2011; Stunkel and Campbell 2011).”
BackgroundHistone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Minucci, S., & Pelicci, P. G. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1779 · Cited by 2,200
Mammalian Sirtuins: Biological Insights and Disease Relevance
Haigis, M. C., & Sinclair, D. A. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092250 · Cited by 2,085
Sirtuins as regulators of metabolism and healthspan
Houtkooper, R. H., Pirinen, E., & Auwerx, J. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3293 · Cited by 2,008
Erasers of Histone Acetylation: The Histone Deacetylase Enzymes
Seto, E., & Yoshida, M. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a018713 · Cited by 1,989
Fraga, M. F., Ballestar, E., Villar-Garea, A., Boix-Chornet, M., Espada, J., Schotta, G., Bonaldi, T., Haydon, C., Ropero, S., Petrie, K., et al. (2005) · Nature Genetics · doi:10.1038/ng1531 · Cited by 1,923
Tan, M., Luo, H., Lee, S., Jin, F., Yang, J. S., Montellier, E., Buchou, T., Cheng, Z., Rousseaux, S., Rajagopal, N., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.008 · Cited by 1,902
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Zuber, J., Shi, J., Wang, E., Rappaport, A. R., Herrmann, H., Sison, E. A., Magoon, D., Qi, J., Blatt, K., Wunderlich, M., et al. (2011) · Nature · doi:10.1038/nature10334 · Cited by 1,870
Histone acetylation and transcriptional regulatory mechanisms
Struhl, K. (1998) · Genes & Development · doi:10.1101/gad.12.5.599 · Cited by 1,815 · cited 1×
“Although HATs are generally associated with transcriptional activity, both HAT and HDAC activity together are required for properly regulated gene expression (Struhl 1998).”
BackgroundEpigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?
Baylin, S. B., & Ohm, J. E. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1799 · Cited by 1,639
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
Morin, R. D., Mendez-Lago, M., Mungall, A. J., Goya, R., Mungall, K. L., Corbett, R. D., Johnson, N. A., Severson, T. M., Chiu, R., Field, M., et al. (2011) · Nature · doi:10.1038/nature10351 · Cited by 1,614
Kuzmichev, A., Nishioka, K., Erdjument-Bromage, H., Tempst, P., & Reinberg, D. (2002) · Genes & Development · doi:10.1101/gad.1035902 · Cited by 1,596
Morin, R. D., Johnson, N. A., Severson, T. M., Mungall, A. J., An, J., Goya, R., Paul, J. E., Boyle, M., Woolcock, B. W., Kuchenbauer, F., et al. (2010) · Nature Genetics · doi:10.1038/ng.518 · Cited by 1,521
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
Dawson, M. A., Prinjha, R. K., Dittmann, A., Giotopoulos, G., Bantscheff, M., Chan, W.-I., Robson, S. C., Chung, C.-W., Hopf, C., Savitski, M. M., et al. (2011) · Nature · doi:10.1038/nature10509 · Cited by 1,503
Kadoch, C., Hargreaves, D. C., Hodges, C., Elias, L., Ho, L., Ranish, J., & Crabtree, G. R. (2013) · Nature Genetics · doi:10.1038/ng.2628 · Cited by 1,458
Epigenetic protein families: a new frontier for drug discovery
Arrowsmith, C. H., Bountra, C., Fish, P. V., Lee, K., & Schapira, M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3674 · Cited by 1,327
Histone Lysine Methylation Dynamics: Establishment, Regulation, and Biological Impact
Black, J. C., Van Rechem, C., & Whetstine, J. R. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.11.006 · Cited by 1,308
Lessons from the Cancer Genome
Garraway, L. A., & Lander, E. S. (2013) · Cell · doi:10.1016/j.cell.2013.03.002 · Cited by 1,308
MLL translocations, histone modifications and leukaemia stem-cell development
Krivtsov, A. V., & Armstrong, S. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2253 · Cited by 1,249
Epigenetic Determinants of Cancer
Baylin, S. B., & Jones, P. A. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a019505 · Cited by 1,226
EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer.
Bracken, A. P., Pasini, D., Capra, M., Prosperini, E., Colli, E., & Helin, K. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg542 · Cited by 1,196
Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
Dalgliesh, G. L., Furge, K., Greenman, C., Chen, L., Bignell, G., Butler, A., Davies, H., Edkins, S., Hardy, C., Latimer, C., et al. (2010) · Nature · doi:10.1038/nature08672 · Cited by 1,173
Targeting MYC dependence in cancer by inhibiting BET bromodomains
Mertz, J. A., Conery, A. R., Bryant, B. M., Sandy, P., Balasubramanian, S., Mele, D. A., Bergeron, L., & Sims, R. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108190108 · Cited by 1,110
Global histone modification patterns predict risk of prostate cancer recurrence
Seligson, D. B., Horvath, S., Shi, T., Yu, H., Tze, S., Grunstein, M., & Kurdistani, S. K. (2005) · Nature · doi:10.1038/nature03672 · Cited by 1,092
Multivalent engagement of chromatin modifications by linked binding modules
Ruthenburg, A. J., Li, H., Patel, D. J., & David Allis, C. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2298 · Cited by 1,013
Human PAD4 Regulates Histone Arginine Methylation Levels via Demethylimination
Wang, Y., Wysocka, J., Sayegh, J., Lee, Y.-H., Perlin, J. R., Leonelli, L., Sonbuchner, L. S., McDonald, C. H., Cook, R. G., Dou, Y., et al. (2004) · Science · doi:10.1126/science.1101400 · Cited by 1,010
Regulation of HP1–chromatin binding by histone H3 methylation and phosphorylation
Fischle, W., Tseng, B. S., Dormann, H. L., Ueberheide, B. M., Garcia, B. A., Shabanowitz, J., Hunt, D. F., Funabiki, H., & Allis, C. D. (2005) · Nature · doi:10.1038/nature04219 · Cited by 993
Inactivating mutations of acetyltransferase genes in B-cell lymphoma
Pasqualucci, L., Dominguez-Sola, D., Chiarenza, A., Fabbri, G., Grunn, A., Trifonov, V., Kasper, L. H., Lerach, S., Tang, H., Ma, J., et al. (2011) · Nature · doi:10.1038/nature09730 · Cited by 949
Doil, C., Mailand, N., Bekker-Jensen, S., Menard, P., Larsen, D. H., Pepperkok, R., Ellenberg, J., Panier, S., Durocher, D., Bartek, J., et al. (2009) · Cell · doi:10.1016/j.cell.2008.12.041 · Cited by 934
Enhancer function: new insights into the regulation of tissue-specific gene expression
Ong, C.-T., & Corces, V. G. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2957 · Cited by 929
Interplay between the Cancer Genome and Epigenome
Shen, H., & Laird, P. W. (2013) · Cell · doi:10.1016/j.cell.2013.03.008 · Cited by 910
de Napoles, M., Mermoud, J. E., Wakao, R., Tang, Y. A., Endoh, M., Appanah, R., Nesterova, T. B., Silva, J., Otte, A. P., Vidal, M., et al. (2004) · Developmental Cell · doi:10.1016/j.devcel.2004.10.005 · Cited by 888
Novel mutations target distinct subgroups of medulloblastoma
Robinson, G., Parker, M., Kranenburg, T. A., Lu, C., Chen, X., Ding, L., Phoenix, T. N., Hedlund, E., Wei, L., Zhu, X., et al. (2012) · Nature · doi:10.1038/nature11213 · Cited by 846
Histone Deimination Antagonizes Arginine Methylation
Cuthbert, G. L., Daujat, S., Snowden, A. W., Erdjument-Bromage, H., Hagiwara, T., Yamada, M., Schneider, R., Gregory, P. D., Tempst, P., Bannister, A. J., et al. (2004) · Cell · doi:10.1016/j.cell.2004.08.020 · Cited by 839
SIRT3 Opposes Reprogramming of Cancer Cell Metabolism through HIF1α Destabilization
Finley, L. W. S., Carracedo, A., Lee, J., Souza, A., Egia, A., Zhang, J., Teruya-Feldstein, J., Moreira, P. I., Cardoso, S. M., Clish, C. B., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.02.014 · Cited by 782
Lysine propionylation and butyrylation are novel post-translational modifications in histones
Chen, Y., Sprung, R., Tang, Y., Ball, H., Sangras, B., Kim, S. C., Falck, J. R., Peng, J., Gu, W., & Zhao, Y. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700021-mcp200 · Cited by 764
SIRT5 Regulates the Mitochondrial Lysine Succinylome and Metabolic Networks
Rardin, M. J., He, W., Nishida, Y., Newman, J. C., Carrico, C., Danielson, S. R., Guo, A., Gut, P., Sahu, A. K., Li, B., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.11.013 · Cited by 713
Schenk, T., Chen, W. C., Göllner, S., Howell, L., Jin, L., Hebestreit, K., Klein, H.-U., Popescu, A. C., Burnett, A., Mills, K., et al. (2012) · Nature Medicine · doi:10.1038/nm.2661 · Cited by 672
The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism
Sebastián, C., Zwaans, B. M. M., Silberman, D. M., Gymrek, M., Goren, A., Zhong, L., Ram, O., Truelove, J., Guimaraes, A. R., Toiber, D., et al. (2012) · Cell · doi:10.1016/j.cell.2012.10.047 · Cited by 660
Histone H3 serine 10 phosphorylation by Aurora B causes HP1 dissociation from heterochromatin
Hirota, T., Lipp, J. J., Toh, B.-H., & Peters, J.-M. (2005) · Nature · doi:10.1038/nature04254 · Cited by 659
Epigenetic Antagonism between Polycomb and SWI/SNF Complexes during Oncogenic Transformation
Wilson, B. G., Wang, X., Shen, X., McKenna, E. S., Lemieux, M. E., Cho, Y.-J., Koellhoffer, E. C., Pomeroy, S. L., Orkin, S. H., & Roberts, C. W. M. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.09.006 · Cited by 654
Iyer, N. G., Özdag, H., & Caldas, C. (2004) · Oncogene · doi:10.1038/sj.onc.1207118 · Cited by 638
Writers and Readers of Histone Acetylation: Structure, Mechanism, and Inhibition
Marmorstein, R., & Zhou, M.-M. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a018762 · Cited by 638
Histone phosphorylation: A chromatin modification involved in diverse nuclear events
Rossetto, D., Avvakumov, N., & Côté, J. (2012) · Epigenetics · doi:10.4161/epi.21975 · Cited by 628
Repression of p53 activity by Smyd2-mediated methylation
Huang, J., Perez-Burgos, L., Placek, B. J., Sengupta, R., Richter, M., Dorsey, J. A., Kubicek, S., Opravil, S., Jenuwein, T., & Berger, S. L. (2006) · Nature · doi:10.1038/nature05287 · Cited by 624
SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation
Barber, M. F., Michishita-Kioi, E., Xi, Y., Tasselli, L., Kioi, M., Moqtaderi, Z., Tennen, R. I., Paredes, S., Young, N. L., Chen, K., et al. (2012) · Nature · doi:10.1038/nature11043 · Cited by 620
Yap, D. B., Chu, J., Berg, T., Schapira, M., Cheng, S.-W. G., Moradian, A., Morin, R. D., Mungall, A. J., Meissner, B., Boyle, M., et al. (2011) · Blood · doi:10.1182/blood-2010-11-321208 · Cited by 606
Mutations truncating the EP300 acetylase in human cancers
Gayther, S. A., Batley, S. J., Linger, L., Bannister, A., Thorpe, K., Chin, S.-F., Daigo, Y., Russell, P., Wilson, A., Sowter, H. M., et al. (2000) · Nature Genetics · doi:10.1038/73536 · Cited by 587
The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells
Harris, W. J., Huang, X., Lynch, J. T., Spencer, G. J., Hitchin, J. R., Li, Y., Ciceri, F., Blaser, J. G., Greystoke, B. F., Jordan, A. M., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.03.014 · Cited by 566
H3K79 Methylation Profiles Define Murine and Human MLL-AF4 Leukemias
Krivtsov, A. V., Feng, Z., Lemieux, M. E., Faber, J., Vempati, S., Sinha, A. U., Xia, X., Jesneck, J., Bracken, A. P., Silverman, L. B., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.001 · Cited by 550
Chase, A., & Cross, N. C. P. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2156 · Cited by 548
Genome-wide Chromatin State Transitions Associated with Developmental and Environmental Cues
Zhu, J., Adli, M., Zou, J. Y., Verstappen, G., Coyne, M., Zhang, X., Durham, T., Miri, M., Deshpande, V., De Jager, P. L., et al. (2013) · Cell · doi:10.1016/j.cell.2012.12.033 · Cited by 545
Acetylation limits 53BP1 association with damaged chromatin to promote homologous recombination
Tang, J., Cho, N. W., Cui, G., Manion, E. M., Shanbhag, N. M., Botuyan, M. V., Mer, G., & Greenberg, R. A. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2499 · Cited by 521
TET2 promotes histone O-GlcNAcylation during gene transcription
Chen, Q., Chen, Y., Bian, C., Fujiki, R., & Yu, X. (2013) · Nature · doi:10.1038/nature11742 · Cited by 511
Global Levels of Histone Modifications Predict Prognosis in Different Cancers
Seligson, D. B., Horvath, S., McBrian, M. A., Mah, V., Yu, H., Tze, S., Wang, Q., Chia, D., Goodglick, L., & Kurdistani, S. K. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080874 · Cited by 508
Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive
Guccione, E., Bassi, C., Casadio, F., Martinato, F., Cesaroni, M., Schuchlautz, H., Lüscher, B., & Amati, B. (2007) · Nature · doi:10.1038/nature06166 · Cited by 491
McCabe, M. T., Graves, A. P., Ganji, G., Diaz, E., Halsey, W. S., Jiang, Y., Smitheman, K. N., Ott, H. M., Pappalardi, M. B., Allen, K. E., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116418109 · Cited by 483
Lim, S., Janzer, A., Becker, A., Zimmer, A., Schüle, R., Buettner, R., & Kirfel, J. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp324 · Cited by 470
EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance
Suvà, M.-L., Riggi, N., Janiszewska, M., Radovanovic, I., Provero, P., Stehle, J.-C., Baumer, K., Le Bitoux, M.-A., Marino, D., Cironi, L., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1622 · Cited by 465
Modulation of p53 Function by SET8-Mediated Methylation at Lysine 382
Shi, X., Kachirskaia, I., Yamaguchi, H., West, L. E., Wen, H., Wang, E. W., Dutta, S., Appella, E., & Gozani, O. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.07.012 · Cited by 462
Comprehensive Catalog of Currently Documented Histone Modifications
Zhao, Y., & Garcia, B. A. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a025064 · Cited by 457
Histone deacetylases and cancer
Barneda-Zahonero, B., & Parra, M. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.07.003 · Cited by 446
Schulte, J. H., Lim, S., Schramm, A., Friedrichs, N., Koster, J., Versteeg, R., Ora, I., Pajtler, K., Klein-Hitpass, L., Kuhfittig-Kulle, S., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1735 · Cited by 445
French, C. A., Ramirez, C. L., Kolmakova, J., Hickman, T. T., Cameron, M. J., Thyne, M. E., Kutok, J. L., Toretsky, J. A., Tadavarthy, A. K., Kees, U. R., et al. (2008) · Oncogene · doi:10.1038/sj.onc.1210852 · Cited by 441
Bell, E. L., Emerling, B. M., Ricoult, S. J. H., & Guarente, L. (2011) · Oncogene · doi:10.1038/onc.2011.37 · Cited by 440
NUP98–NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis
Wang, G. G., Cai, L., Pasillas, M. P., & Kamps, M. P. (2007) · Nature Cell Biology · doi:10.1038/ncb1608 · Cited by 437
Citrullination regulates pluripotency and histone H1 binding to chromatin
Christophorou, M. A., Castelo-Branco, G., Halley-Stott, R. P., Oliveira, C. S., Loos, R., Radzisheuskaya, A., Mowen, K. A., Bertone, P., Silva, J. C. R., Zernicka-Goetz, M., et al. (2014) · Nature · doi:10.1038/nature12942 · Cited by 412
Signaling Network Model of Chromatin
Schreiber, S. L., & Bernstein, B. E. (2002) · Cell · doi:10.1016/s0092-8674(02)01196-0 · Cited by 393
Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth
Lin, R., Tao, R., Gao, X., Li, T., Zhou, X., Guan, K.-L., Xiong, Y., & Lei, Q.-Y. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.07.002 · Cited by 384
β- N -acetylglucosamine (O-GlcNAc) is part of the histone code
Sakabe, K., Wang, Z., & Hart, G. W. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009023107 · Cited by 373
Chen, M.-W., Hua, K.-T., Kao, H.-J., Chi, C.-C., Wei, L.-H., Johansson, G., Shiah, S.-G., Chen, P.-S., Jeng, Y.-M., Cheng, T.-Y., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0833 · Cited by 369
Crosstalk among Histone Modifications
Suganuma, T., & Workman, J. L. (2008) · Cell · doi:10.1016/j.cell.2008.10.036 · Cited by 369
The super elongation complex (SEC) and MLL in development and disease
Smith, E., Lin, C., & Shilatifard, A. (2011) · Genes & Development · doi:10.1101/gad.2015411 · Cited by 361
Stewart, M. D., Li, J., & Wong, J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.7.2525-2538.2005 · Cited by 351
Expression profile of class I histone deacetylases in human cancer tissues
Nakagawa, M., Oda, Y., Eguchi, T., Aishima, S.-I., Yao, T., Hosoi, F., Basaki, Y., Ono, M., Kuwano, M., Tanaka, M., et al. (2007) · Oncology Reports · doi:10.3892/or.18.4.769 · Cited by 341
The Dual Role of Sirtuins in Cancer
Bosch-Presegue, L., & Vaquero, A. (2011) · Genes & Cancer · doi:10.1177/1947601911417862 · Cited by 329
Lockwood, W. W., Zejnullahu, K., Bradner, J. E., & Varmus, H. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216363109 · Cited by 327
Macrodomain-containing proteins are new mono-ADP-ribosylhydrolases
Rosenthal, F., Feijs, K. L. H., Frugier, E., Bonalli, M., Forst, A. H., Imhof, R., Winkler, H. C., Fischer, D., Caflisch, A., Hassa, P. O., et al. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2521 · Cited by 315
Crosstalk between CARM1 Methylation and CBP Acetylation on Histone H3
Daujat, S., Bauer, U.-M., Shah, V., Turner, B., Berger, S., & Kouzarides, T. (2002) · Current Biology · doi:10.1016/s0960-9822(02)01387-8 · Cited by 313
PRMT6-mediated methylation of R2 in histone H3 antagonizes H3 K4 trimethylation
Hyllus, D., Stein, C., Schnabel, K., Schiltz, E., Imhof, A., Dou, Y., Hsieh, J., & Bauer, U.-M. (2007) · Genes & Development · doi:10.1101/gad.447007 · Cited by 306
Fan, J., Shan, C., Kang, H.-B., Elf, S., Xie, J., Tucker, M., Gu, T.-L., Aguiar, M., Lonning, S., Chen, H., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2013.12.026 · Cited by 305 · cited 3×
“Continued 22 Cite this article as Cold Spring Harb Perspect Biol 2016;8:a019521 Appendix C. Selected histone methyltransferases in cancer Name Synonyms Histone target(s) Links to cancer KMT1A SUV39H1 H3K9 Overexpressed in colorectal cancer (Kang et al. 2007), associated with transcriptional repression KMT1C G9a, EHMT2…”
BackgroundRegulation of Estrogen Receptor α by the SET7 Lysine Methyltransferase
Subramanian, K., Jia, D., Kapoor-Vazirani, P., Powell, D. R., Collins, R. E., Sharma, D., Peng, J., Cheng, X., & Vertino, P. M. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.022 · Cited by 290
Fontebasso, A. M., Schwartzentruber, J., Khuong-Quang, D.-A., Liu, X.-Y., Sturm, D., Korshunov, A., Jones, D. T. W., Witt, H., Kool, M., Albrecht, S., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1095-8 · Cited by 290
Endoh, M., Endo, T. A., Endoh, T., Fujimura, Y.-I., Ohara, O., Toyoda, T., Otte, A. P., Okano, M., Brockdorff, N., Vidal, M., et al. (2008) · Development · doi:10.1242/dev.014340 · Cited by 290
p300 gene alterations in colorectal and gastric carcinomas.
Muraoka, M., Konishi, M., Kikuchi‐Yanoshita, R., Tanaka, K., Shitara, N., Chong, J., Iwama∥, T., & Miyaki, M. (1996) · PubMed · Cited by 282
Serrano, L., Martínez-Redondo, P., Marazuela-Duque, A., Vazquez, B. N., Dooley, S. J., Voigt, P., Beck, D. B., Kane-Goldsmith, N., Tong, Q., Rabanal, R. M., et al. (2013) · Genes & Development · doi:10.1101/gad.211342.112 · Cited by 281
Versatility of PRMT5-induced methylation in growth control and development
Karkhanis, V., Hu, Y.-J., Baiocchi, R. A., Imbalzano, A. N., & Sif, S. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.09.001 · Cited by 280
c-Myb and p300 Regulate Hematopoietic Stem Cell Proliferation and Differentiation
Sandberg, M. L., Sutton, S. E., Pletcher, M. T., Wiltshire, T., Tarantino, L. M., Hogenesch, J. B., & Cooke, M. P. (2005) · Developmental Cell · doi:10.1016/j.devcel.2004.12.015 · Cited by 279
Histone Acetylation Regulates Intracellular pH
McBrian, M. A., Behbahan, I. S., Ferrari, R., Su, T., Huang, T.-W., Li, K., Hong, C. S., Christofk, H. R., Vogelauer, M., Seligson, D. B., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2012.10.025 · Cited by 272
Mozzetta, C., Pontis, J., Fritsch, L., Robin, P., Portoso, M., Proux, C., Margueron, R., & Ait-Si-Ali, S. (2014) · Molecular Cell · doi:10.1016/j.molcel.2013.12.005 · Cited by 272
PARP1 ADP-ribosylates lysine residues of the core histone tails
Messner, S., Altmeyer, M., Zhao, H., Pozivil, A., Roschitzki, B., Gehrig, P., Rutishauser, D., Huang, D., Caflisch, A., & Hottiger, M. O. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq463 · Cited by 264
Transcriptional Silencing by Polycomb-Group Proteins
Grossniklaus, U., & Paro, R. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a019331 · Cited by 263
Increased PADI4 expression in blood and tissues of patients with malignant tumors
Chang, X., Han, J., Pang, L., Zhao, Y., Yang, Y., & Shen, Z. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-40 · Cited by 255
Fang, J., Chen, T., Chadwick, B., Li, E., & Zhang, Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400493200 · Cited by 249
The Leukemogenicity of AML1-ETO Is Dependent on Site-Specific Lysine Acetylation
Wang, L., Gural, A., Sun, X.-J., Zhao, X., Perna, F., Huang, G., Hatlen, M. A., Vu, L., Liu, F., Xu, H., et al. (2011) · Science · doi:10.1126/science.1201662 · Cited by 242
BMI1 Is Recruited to DNA Breaks and Contributes to DNA Damage-Induced H2A Ubiquitination and Repair
Ginjala, V., Nacerddine, K., Kulkarni, A., Oza, J., Hill, S. J., Yao, M., Citterio, E., van Lohuizen, M., & Ganesan, S. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.00981-10 · Cited by 240
Kaeser, M. D., Aslanian, A., Dong, M.-Q., Yates, J. R., & Emerson, B. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806061200 · Cited by 236
Mechanisms of epigenetic inheritance
Martin, C., & Zhang, Y. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.04.002 · Cited by 236
Venneti, S., Garimella, M. T., Sullivan, L. M., Martinez, D., Huse, J. T., Heguy, A., Santi, M., Thompson, C. B., & Judkins, A. R. (2013) · Brain Pathology · doi:10.1111/bpa.12042 · Cited by 235
Kondo, Y., Shen, L., Ahmed, S., Boumber, Y., Sekido, Y., Haddad, B. R., & Issa, J.-P. J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002037 · Cited by 234
Hakimi, A. A., Chen, Y.-B., Wren, J., Gonen, M., Abdel-Wahab, O., Heguy, A., Liu, H., Takeda, S., Tickoo, S. K., Reuter, V. E., et al. (2013) · European Urology · doi:10.1016/j.eururo.2012.09.005 · Cited by 231
Yang, Z., Imoto, I., Fukuda, Y., Pimkhaokham, A., Shimada, Y., Imamura, M., Sugano, S., Nakamura, Y., & Inazawa, J. (2000) · PubMed · Cited by 228
Histone deacetylase 10 promotes autophagy-mediated cell survival
Oehme, I., Linke, J.-P., Böck, B. C., Milde, T., Lodrini, M., Hartenstein, B., Wiegand, I., Eckert, C., Roth, W., Kool, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300113110 · Cited by 221
Regulation of p53 Target Gene Expression by Peptidylarginine Deiminase 4
Li, P., Yao, H., Zhang, Z., Li, M., Luo, Y., Thompson, P. R., Gilmour, D. S., & Wang, Y. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01747-07 · Cited by 220
Zhang, X., Bolt, M., Guertin, M. J., Chen, W., Zhang, S., Cherrington, B. D., Slade, D. J., Dreyton, C. J., Subramanian, V., Bicker, K. L., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203280109 · Cited by 211
Histone Lysine Methyltransferase SETD8 Promotes Carcinogenesis by Deregulating PCNA Expression
Takawa, M., Cho, H.-S., Hayami, S., Toyokawa, G., Kogure, M., Yamane, Y., Iwai, Y., Maejima, K., Ueda, K., Masuda, A., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3701 · Cited by 211
Kauffman, E. C., Robinson, B. D., Downes, M. J., Powell, L. G., Lee, M. M., Scherr, D. S., Gudas, L. J., & Mongan, N. P. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20758 · Cited by 210
Jiang, T., Zhou, X., Taghizadeh, K., Dong, M., & Dedon, P. C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606775103 · Cited by 208
He, J., Nguyen, A. T., & Zhang, Y. (2011) · Blood · doi:10.1182/blood-2010-10-312736 · Cited by 207
Wyce, A., Ganji, G., Smitheman, K. N., Chung, C.-W., Korenchuk, S., Bai, Y., Barbash, O., Le, B., Craggs, P. D., McCabe, M. T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072967 · Cited by 206
BRD4 Bromodomain Gene Rearrangement in Aggressive Carcinoma with Translocation t(15;19)
French, C. A., Miyoshi, I., Aster, J. C., Kubonishi, I., Kroll, T. G., Dal Cin, P., Vargas, S. O., Perez-Atayde, A. R., & Fletcher, J. A. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63049-0 · Cited by 206
Liu, G., Bollig-Fischer, A., Kreike, B., van de Vijver, M. J., Abrams, J., Ethier, S. P., & Yang, Z. Q. (2009) · Oncogene · doi:10.1038/onc.2009.297 · Cited by 202
BRD7 is a candidate tumour suppressor gene required for p53 function
Drost, J., Mantovani, F., Tocco, F., Elkon, R., Comel, A., Holstege, H., Kerkhoven, R., Jonkers, J., Voorhoeve, P. M., Agami, R., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2038 · Cited by 199
Kawazu, M., Saso, K., Tong, K. I., McQuire, T., Goto, K., Son, D.-O., Wakeham, A., Miyagishi, M., Mak, T. W., & Okada, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017830 · Cited by 198
Hsia, D. A., Tepper, C. G., Pochampalli, M. R., Hsia, E. Y. C., Izumiya, C., Huerta, S. B., Wright, M. E., Chen, H.-W., Kung, H.-J., & Izumiya, Y. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000401107 · Cited by 195
Haigis, M. C., Deng, C.-X., Finley, L. W. S., Kim, H.-S., & Gius, D. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3633 · Cited by 194
KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling
Wagner, K. W., Alam, H., Dhar, S. S., Giri, U., Li, N., Wei, Y., Giri, D., Cascone, T., Kim, J.-H., Ye, Y., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68642 · Cited by 193
Multiple roles of class I HDACs in proliferation, differentiation, and development
Reichert, N., Choukrallah, M.-A., & Matthias, P. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-0921-9 · Cited by 192
Dhar, S. S., Lee, S.-H., Kan, P.-Y., Voigt, P., Ma, L., Shi, X., Reinberg, D., & Lee, M. G. (2012) · Genes & Development · doi:10.1101/gad.203356.112 · Cited by 190
Fiskus, W., Sharma, S., Qi, J., Valenta, J. A., Schaub, L. J., Shah, B., Peth, K., Portier, B. P., Rodriguez, M., Devaraj, S. G. T., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0770 · Cited by 190
Yan, F., Alinari, L., Lustberg, M. E., Katherine Martin, L., Cordero-Nieves, H. M., Banasavadi-Siddegowda, Y., Virk, S., Barnholtz-Sloan, J., Bell, E. H., Wojton, J., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-0884 · Cited by 180
Cancers with wrong HATs: the impact of acetylation
Di Cerbo, V., & Schneider, R. (2013) · Briefings in Functional Genomics · doi:10.1093/bfgp/els065 · Cited by 178
Angrand, P.-O., Apiou, F., Stewart, A. F., Dutrillaux, B., Losson, R., & Chambon, P. (2001) · Genomics · doi:10.1006/geno.2001.6524 · Cited by 177
Komatsu, S., Imoto, I., Tsuda, H., Kozaki, K.-I., Muramatsu, T., Shimada, Y., Aiko, S., Yoshizumi, Y., Ichikawa, D., Otsuji, E., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp116 · Cited by 173
Push back to respond better: regulatory inhibition of the DNA double-strand break response
Panier, S., & Durocher, D. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3659 · Cited by 170
Mammalian DNA repair: HATs and HDACs make their mark through histone acetylation
Gong, F., & Miller, K. M. (2013) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2013.07.002 · Cited by 170
Smyd3 regulates cancer cell phenotypes and catalyzes histone H4 lysine 5 methylation
Van Aller, G. S., Reynoird, N., Barbash, O., Huddleston, M., Liu, S., Zmoos, A.-F., McDevitt, P., Sinnamon, R., Le, B., Mas, G., et al. (2012) · Epigenetics · doi:10.4161/epi.19506 · Cited by 170
Monoubiquitination of H2AX Protein Regulates DNA Damage Response Signaling
Pan, M.-R., Peng, G., Hung, W.-C., & Lin, S.-Y. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.256297 · Cited by 167
Histone H4 deacetylation facilitates 53BP1 DNA damage signaling and double-strand break repair
Hsiao, K., & Mizzen, C. A. (2013) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjs066 · Cited by 166
Chen, H.-C., Jeng, Y.-M., Yuan, R.-H., Hsu, H.-C., & Chen, Y.-L. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-011-2159-4 · Cited by 165
Wiśniewski, J. R., Zougman, A., & Mann, M. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkm1057 · Cited by 163
Tweedie-Cullen, R. Y., Brunner, A. M., Grossmann, J., Mohanna, S., Sichau, D., Nanni, P., Panse, C., & Mansuy, I. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036980 · Cited by 163
Watanabe, H., Soejima, K., Yasuda, H., Kawada, I., Nakachi, I., Yoda, S., Naoki, K., & Ishizaka, A. (2008) · Cancer Cell International · doi:10.1186/1475-2867-8-15 · Cited by 160
Trojer, P., Cao, A. R., Gao, Z., Li, Y., Zhang, J., Xu, X., Li, G., Losson, R., Erdjument‐Bromage, H., Tempst, P., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.04.004 · Cited by 159
Hu, S., Yu, L., Li, Z., Shen, Y., Wang, J., Cai, J., Xiao, L., & Wang, Z. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.8.12913 · Cited by 159
Regulation of histone modification and chromatin structure by the p53–PADI4 pathway
Tanikawa, C., Espinosa‐Cantellano, M., Suzuki, A., Masuda, K., Yamamoto, K., Tsuchiya, E., Ueda, K., Daigo, Y., Nakamura, Y., & Matsuda, K. (2012) · Nature Communications · doi:10.1038/ncomms1676 · Cited by 158
Sirtuin 1 (SIRT1): The Misunderstood HDAC
Stünkel, W., & Campbell, R. M. (2011) · SLAS DISCOVERY · doi:10.1177/1087057111422103 · Cited by 157
Self-citationCancer epigenetics drug discovery and development: the challenge of hitting the mark
Campbell, R. M., & Tummino, P. J. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71605 · Cited by 157
Self-citationA687V EZH2 is a gain‐of‐function mutation found in lymphoma patients
Majer, C. R., Jin, L., Scott, M. P., Knutson, S. K., Kuntz, K. W., Keilhack, H., Smith, J. J., Moyer, M. P., Richon, V. M., Copeland, R. A., et al. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.07.066 · Cited by 154
Yang, P. X., Guo, L., Duan, Z., Tepper, C. G., Xue, L., Chen, X., Kung, H., Gao, A. C., Zou, J. X., & Chen, H.-W. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00204-12 · Cited by 153
Anderton, J. A., Bose, S., Vockerodt, M., Vrzalikova, K., Wei, W., Kuo, M., Helin, K., Christensen, J. F., Rowe, M., Murray, P. G., et al. (2011) · Oncogene · doi:10.1038/onc.2010.579 · Cited by 152
Crea, F., Nobili, S., Paolicchi, E., Perrone, G., Napoli, C., Landini, I., Danesi, R., & Mini, E. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.08.001 · Cited by 140
Khan, S. N., Jankowska, A. M., Mahfouz, R. Z., Dunbar, A. J., Sugimoto, Y., Hosono, N., Hu, Z., Cheriyath, V., Vatolin, S., Przychodzen, B. P., et al. (2013) · Leukemia · doi:10.1038/leu.2013.80 · Cited by 139
SET7/9 mediated methylation of non-histone proteins in mammalian cells
Pradhan, S., Chin, H. G., Estève, P., & Jacobsen, S. E. (2009) · Epigenetics · doi:10.4161/epi.4.6.9450 · Cited by 137
Jung, K. H., Noh, J. H., Kim, J. K., Eun, J. W., Bae, H. J., Xie, H. J., Chang, Y. G., Kim, M., Park, H., Lee, J. Y., et al. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24090 · Cited by 135
Epigenetic Control of ImmunityPreprint
Busslinger, M., & Tarakhovsky, A. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a019307 · Cited by 135
Bromodomains and Their Pharmacological Inhibitors
Gallenkamp, D., Gelato, K. A., Haendler, B., & Weinmann, H. (2014) · ChemMedChem · doi:10.1002/cmdc.201300434 · Cited by 129
Dorrance, A. M., Liu, S., Yuan, W., Becknell, B., Arnoczky, K. J., Guimond, M., Strout, M. P., Feng, L., Nakamura, T., Yu, L., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25546 · Cited by 128
Structural and Functional Coordination of DNA and Histone MethylationPreprint
Cheng, X. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a018747 · Cited by 128
Histone deacetylases and epigenetic therapies of hematological malignancies
Mercurio, C., Minucci, S., & Pelicci, P. G. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.02.010 · Cited by 126
Vinatzer, U., Gollinger, M., Müllauer, L., Raderer, M., Chott, A., & Streubel, B. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0702 · Cited by 126
Harte, M. T., O'Brien, G. J., Ryan, N., Gorski, J. J., Savage, K. I., Crawford, N., Mullan, P. B., & Harkin, D. P. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2089 · Cited by 120
Gene Amplification and Overexpression of PRDM14 in Breast Cancers
Nishikawa, N., Toyota, M., Suzuki, H., Honma, T., Fujikane, T., Ohmura, T., Nishidate, T., Ohe-Toyota, M., Maruyama, R., Sonoda, T., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4111 · Cited by 116
The role of histone demethylases in cancer therapy
Hoffmann, I., Roatsch, M., Schmitt, M., Carlino, L., Pippel, M., Sippl, W., & Jung, M. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.07.004 · Cited by 114
HDAC11 is a novel drug target in carcinomas
Deubzer, H. E., Schier, M. C., Oehme, I., Lodrini, M., Haendler, B., Sommer, A., & Witt, O. (2013) · International Journal of Cancer · doi:10.1002/ijc.27876 · Cited by 112
The Discovery of Histone DemethylasesPreprint
Shi, Y. G., & Tsukada, Y.-I. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a017947 · Cited by 111
SIRT2 directs the replication stress response through CDK9 deacetylation
Zhang, H., Park, S., Pantazides, B. G., Karpiuk, O., Warren, M. D., Hardy, C. W., Duong, D. M., Park, S., Kim, H. S., Vassilopoulos, A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301463110 · Cited by 110
The JMJD2A demethylase regulates apoptosis and proliferation in colon cancer cells
Kim, T., Shin, S., Berry, W. L., Oh, S., & Janknecht, R. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24009 · Cited by 108
Citrullination of Histone H3 Interferes with HP1-Mediated Transcriptional Repression
Sharma, P., Azébi, S., England, P., Christensen, T., Møller-Larsen, A., Petersen, T., Batsché, É., & Muchardt, C. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002934 · Cited by 107
Deregulated expression of selected histone methylases and demethylases in prostate carcinoma
Vieira, F. Q., Costa‐Pinheiro, P., Ramalho-Carvalho, J., Faria‐Pereira, A., Menezes, F. D., Antunes, L., Carneiro, I. C., Oliveira, J., Henrique, R., & Jerónimo, C. (2013) · Endocrine Related Cancer · doi:10.1530/erc-13-0375 · Cited by 103
Calés, C., Román-Trufero, M., Pavón, L., Serrano, I., Melgar, T., Endoh, M., Pérez‐Martínez, C., Koseki, H., & Vidal, M. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01136-07 · Cited by 100
A Structural Perspective on Readout of Epigenetic Histone and DNA Methylation MarksPreprint
Patel, D. J. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a018754 · Cited by 100
SIRT2: Tumour suppressor or tumour promoter in operable breast cancer?
McGlynn, L. M., Zino, S., Macdonald, A. I., Curle, J., Reilly, J. E., Mohammed, Z. M. A., McMillan, D. C., Mallon, E., Payne, A. P., Edwards, J., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.10.005 · Cited by 99
Functional Connection between Deimination and Deacetylation of Histones
Denis, H., Deplus, R., Putmans, P., Yamada, M., Métivier, R., & Fuks, F. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00285-09 · Cited by 99
Chung, J.-H., Karkhanis, V. A., Tae, S., Yan, F., Smith, P. L., Ayers, L. W., Agostinelli, C., Pileri, S. A., Denis, G. V., Baiocchi, R. A., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.510669 · Cited by 97
Uemura, M., Yamamoto, H., Takemasa, I., Mimori, K., Hemmi, H., Mizushima, T., Ikeda, M., Sekimoto, M., Matsuura∥, N., Doki, Y., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0407 · Cited by 97
MMSET stimulates myeloma cell growth through microRNA-mediated modulation of c-MYC
Min, D.-J., Ezponda, T., Kim, M. K., Will, C., Martínez-García, E., Popovic, R., Basrur, V., Elenitoba‐Johnson, K. S. J., & Licht, J. D. (2012) · Leukemia · doi:10.1038/leu.2012.269 · Cited by 95
Mitra, D., Das, P. M., Huynh, F. C., & Jones, F. E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.304865 · Cited by 94
Nicholas, C., Yang, J., Peters, S. B., Bill, M. A., Baiocchi, R. A., Yan, F., Sif, S., Tae, S., Gaudio, E., Wu, X., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074710 · Cited by 88
Damme, M. V., Crompot, E., Meuleman, N., Mineur, P., Bron, D., Lagneaux, L., & Stamatopoulos, B. (2012) · Epigenetics · doi:10.4161/epi.22674 · Cited by 86
Park, S., Zhu, Y., Özden, Ö., Kim, H. S., Jiang, H., Deng, C., Gius, D. R., & Vassilopoulos, A. (2012) · PubMed · Cited by 85
Qi, J. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a018663 · Cited by 84
CLLD8/KMT1F Is a Lysine Methyltransferase That Is Important for Chromosome Segregation
Falandry, C., Fourel, G., Galy, V., Ristriani, T., Horard, B., Simon, E. B., Salles, G., Gilson, É., & Magdinier, F. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.052399 · Cited by 81
Osawa, T., Muramatsu, M., Wang, F., Tsuchida, R., Kodama, T., Minami, T., & Shibuya, M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108462109 · Cited by 81
Pinder, J. B., Attwood, K. M., & Dellaire, G. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00045 · Cited by 80
RBP2‐H1/JARID1B is a transcriptional regulator with a tumor suppressive potential in melanoma cells
Roesch, A., Mueller, A. M., Stempfl, T., Moehle, C., Landthaler, M., & VOGT, T. M. (2007) · International Journal of Cancer · doi:10.1002/ijc.23211 · Cited by 79
Campbell, S. J., Edwards, R. A., Leung, C. C. Y., Neculai, D., Hodge, C. D., Dhe‐Paganon, S., & Glover, J. N. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.359653 · Cited by 79
Methylation specifies distinct estrogen-induced binding site repertoires of CBP to chromatinPreprint
Ceschin, D. G., Walia, M., Wenk, S. S., Duboé, C., Gaudon, C., Xiao, Y., Fauquier, L., Sankar, M., Vandel, L., & Gronemeyer, H. (2011) · Genes & Development · doi:10.1101/gad.619211 · Cited by 79
Kang, D., Cho, H., Toyokawa, G., Kogure, M., Yamane, Y., Iwai, Y., Hayami, S., Tsunoda, T., Field, H. I., Matsuda, K., et al. (2012) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22012 · Cited by 78
Li, W., Zhao, L., Zang, W., Liu, Z., Chen, L., Liu, T., Xu, D., & Jia, J. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.11.045 · Cited by 77
Regulation of Tumor Suppressor p53 and HCT116 Cell Physiology by Histone Demethylase JMJD2D/KDM4D
Kim, T., Oh, S., Shin, S., & Janknecht, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034618 · Cited by 76
Targeting Histone Deacetylases in Neuroblastoma
Witt, O., Deubzer, H. E., Lodrini, M., Milde, T., & Oehme, I. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209787315774 · Cited by 70
Saeed, S., Logie, C., Françoijs, K., Frigè, G., Romanenghi, M., Nielsen, F. G. G., Raats, L., Shahhoseini, M., Huynen, M. A., Altucci, L., et al. (2012) · Blood · doi:10.1182/blood-2011-10-386086 · Cited by 69
Molecular Pathways: Emerging Roles of Mammalian Sirtuin SIRT7 in Cancer
Paredes, S., Villanova, L., & Chua, K. F. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1547 · Cited by 65
HDAC modulation and cell death in the clinic
Dell’Aversana, C., Lepore, I., & Altucci, L. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.01.025 · Cited by 64
Migliori, V., Phalke, S., Bezzi, M., & Guccione, E. (2010) · Epigenomics · doi:10.2217/epi.09.39 · Cited by 63
Deregulation of protein methylation in melanoma
Limm, K., Ott, C., Wallner, S., Mueller, D. W., Oefner, P. J., Hellerbrand, C., & Bosserhoff, A. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.11.026 · Cited by 63
Dettman, E. J., Simko, S. J., Ayanga, B. A., Carofino, B. L., Margolin, J., Morse, H. C., & Justice, M. J. (2011) · Oncogene · doi:10.1038/onc.2011.12 · Cited by 62
Small-Molecule Ligands of Methyl-Lysine Binding Proteins: Optimization of Selectivity for L3MBTL3
James, L. I., Korboukh, V. K., Krichevsky, L., Baughman, B. M., Herold, J. M., Norris, J. L., Jin, J. J., Kireev, D., Janzen, W. P., Arrowsmith, C. H., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400919p · Cited by 62
Disordered epigenetic regulation in MLL-related leukemia
Zhang, Y., Chen, A., Yan, X., & Huang, G. (2012) · International Journal of Hematology · doi:10.1007/s12185-012-1180-0 · Cited by 61
Cited by
Hallmarks of Cancer: New Dimensions
Hanahan, D. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1059 · Cited by 9,887
The molecular hallmarks of epigenetic control
Allis, C. D., & Jenuwein, T. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.59 · Cited by 2,809
Epigenetic Determinants of Cancer
Baylin, S. B., & Jones, P. A. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a019505 · Cited by 1,226
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
Cheng, Y., He, C., Wang, M., Ma, X., Mo, F., Yang, S., Han, J., & Wei, X. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0095-0 · Cited by 1,097
“In addition to those mentioned and discussed above, histone modifications also include citrullination, ADP-ribosylation, deamination, formylation, O-GlcNAcylation, propionylation, butyrylation, crotonylation, and proline isomerization at over 60 amino acid residues.(157,158) In addition to conventional PTMs, novel PTM…”
BackgroundHeavy metals: toxicity and human health effects
Jomova, K., Alomar, S. Y., Nepovimova, E., Kuca, K., & Valko, M. (2025) · Archives of Toxicology · doi:10.1007/s00204-024-03903-2 · Cited by 983
Metadata
- Authors
- Audia, J. E., & Campbell, R. M.
- Venue
- Cold Spring Harbor Perspectives in Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2016-04
- Volume
- 8
- Issue
- 4
- Pages
- a019521
- ISSN
- 1943-0264 (ISSN-L)
- OpenAlex
- W2323939601
- Cited by
- 1,024
- References
- 229
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.